These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17685185)

  • 1. [Clinical differences between heart failure versus ischemic patients].
    Pinelli M; Bindi M; Moroni F; Rosada J; Castiglioni M
    Recenti Prog Med; 2007; 98(7-8):378-83. PubMed ID: 17685185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uric acid as a marker of pathophysiological mechanisms in patients with cardiovascular disease].
    Calberg MJ; Kjøller E
    Ugeskr Laeger; 2005 Oct; 167(40):3771-4. PubMed ID: 16221391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non-ischaemic origin.
    Campolo J; Caruso R; De Maria R; Parolini M; Oliva F; Roubina E; Cighetti G; Frigerio M; Vitali E; Parodi O
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1024-8. PubMed ID: 18163014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
    Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
    Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of Atherosclerosis, Clinical Characteristics, and Treatment Patterns in Heart Failure: A Case-Control Study of Middle-Aged Adult Heart Failure Patients in Rural Kenya.
    Bloomfield GS; DeLong AK; Akwanalo CO; Hogan JW; Carter EJ; Aswa DF; Binanay C; Koech M; Kimaiyo S; Velazquez EJ
    Glob Heart; 2016 Mar; 11(1):97-107. PubMed ID: 27102027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to ischemic heart disease, coronary care, and severe heart failure (including cardiogenic shock).
    Fein SA; Breisblatt W; Doyle JT; Singh A
    Clin Geriatr Med; 1994 Feb; 10(1):145-60. PubMed ID: 8168020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: A hospital cohort study.
    Haugen E; Furukawa Y; Isic A; Fu M
    Int J Cardiol; 2008 Apr; 125(2):216-9. PubMed ID: 18234365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of diurnal variation of P-wave and QT dispersions in patients with heart failure.
    Gunes Y; Tuncer M; Guntekin U; Akdag S; Gumrukcuoglu HA
    Pacing Clin Electrophysiol; 2008 Aug; 31(8):974-8. PubMed ID: 18684253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of uric acid in heart failure].
    Alcaíno H; Greig D; Castro P; Verdejo H; Mellado R; García L; Díaz-Araya G; Quiroga C; Chiong M; Lavandero S
    Rev Med Chil; 2011 Apr; 139(4):505-15. PubMed ID: 21879191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan improves heart rate variability and heart rate turbulence in heart failure due to ischemic cardiomyopathy.
    Ozdemir M; Arslan U; Türkoğlu S; Balcioğlu S; Cengel A
    J Card Fail; 2007 Dec; 13(10):812-7. PubMed ID: 18068613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
    Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C
    Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urocortins in heart failure and ischemic heart disease.
    Boonprasert P; Lailerd N; Chattipakorn N
    Int J Cardiol; 2008 Jul; 127(3):307-12. PubMed ID: 18180061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin, a new prognostic biomarker in patients with chronic heart failure.
    Rosenberg M; Zugck C; Nelles M; Juenger C; Frank D; Remppis A; Giannitsis E; Katus HA; Frey N
    Circ Heart Fail; 2008 May; 1(1):43-9. PubMed ID: 19808269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study.
    Demir M; Kanadasi M; Akpinar O; Dönmez Y; Avkarogullari M; Alhan C; Inal T; San M; Usal A; Demirtas M
    Angiology; 2007; 58(5):603-9. PubMed ID: 18024945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
    Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac peptides during exercise test in ischemic and non-ischemic heart failure patients.
    Ilea M; Zdrenghea D; Bodisz G; Mălai A; Gheorghiu L; Predescu D; Beudean M; Ossian V; Gligor E; Vlad C; Pop D; Bogdan E; Roşu R
    Rom J Intern Med; 2008; 46(1):63-8. PubMed ID: 19157272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trial.
    Zwisler AD; Soja AM; Rasmussen S; Frederiksen M; Abedini S; Appel J; Rasmussen H; Gluud C; Iversen L; Sigurd B; Madsen M; Fischer-Hansen J;
    Am Heart J; 2008 Jun; 155(6):1106-13. PubMed ID: 18513526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure.
    Horwich TB; Hernandez AF; Dai D; Yancy CW; Fonarow GC
    Am Heart J; 2008 Dec; 156(6):1170-6. PubMed ID: 19033015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum uric acid in acute myocardial infarction.
    Nadkar MY; Jain VI
    J Assoc Physicians India; 2008 Oct; 56():759-62. PubMed ID: 19263700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.